Abstract
Introduction Most patients with psychotic disorders in Africa initially use alternative and complementary therapies leading to delays accessing evidence-based treatments. This delay, known as the duration of untreated psychosis (DUP), is associated with suboptimal response and reduced efficacy in short-term and long-term outcomes. In this study, we explore facilitators for transitioning from alternative and complementary therapies to evidence-based treatments for psychotic disorders, comparing these facilitators between patients and their caregivers.
Methods The study was conducted at Butabika hospital in Kampala, Uganda. Participants included patients with first-episode psychosis who had used alternative and complementary therapies and their caregivers. An exploratory qualitative design using in-depth interviews was performed with thematic analysis used to analyze the data.
Results We interviewed eight patients and eight caregivers. The key themes that led to a switch were the high cost of alternative therapies, a desire to know the cause of the illness, seeking better care and the influence of friends and community members. Themes were similar among the participants and their caregivers except for stigma, which was only found among the caregivers.
Conclusions The reasons for transitioning from alternative and complementary therapies to evidence-based treatments are similar between patients and caregivers, except for stigma that is a more important factor for transition among caregivers. Since this was an exploratory study, additional research with a larger sample and more diverse population would enable a deeper understanding of these factors and guide the development of interventions to reduce DUP and improve outcomes for psychotic disorders.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://pubmed.ncbi.nlm.nih.gov/31315866/
Funding Statement
This project is supported by the Fogarty International Centre (FIC) and the National Institutes of Mental Health of the National Institute of Health (NIH) under award number D43TW009343 and the University of California Global Health Institute (UCGHI). The consent is solely the responsibility of the authors and does not necessarily represent the official views of the NHI or UCGHI.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was received from ethics committees at the school of medicine research and ethics committee of the college of health sciences at Makerere University (REC REF 2017153) as well as the Uganda National Council of Science and Technology (HS237ES). Informed consent was obtained from all study participants before enrolment and signed consent forms are available. Participants and caregivers were each reimbursed six dollars (approximately sh20 000) for their time, either on completion of the full study assessment or when consent was withdrawn. No individual participant data has been reported.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author emails: Dr Emmanuel K. Mwesiga, MBChB, MMED, PhD; UCGHI GloCal Global Health Fellow at the Infectious Diseases Institute emmanuel.mwesiga{at}mak.ac.ug
Mr Andrew S. Ssemata, MSc; Department of Psychiatry, Makerere University andrewssemata{at}yahoo.co.uk
Ms Ann Jacquelline Nakitende MSc; Department of Psychiatry, Makerere University janakitex{at}yahoo.com
Dr Linnet Ongeri MBChB; MMED (Psych), Kenya Medical Research Institute; linongeri{at}gmail.com
Dr Aggrey Semeere MBChB, MMED, MAS; Infectious Diseases Institute, Makerere University. asemeere{at}gmail.com
Dr Rachel Loewy PhD; Professor, Department of Psychiatry, University of California, San Francisco. Rachel.Loewy{at}ucsf.edu
Dr Susan Meffert MD, MPH, Associate Professor, Department of Psychiatry, University of California, San Francisco. Susan.Meffert{at}ucsf.edu
Prof. Noeline Nakasujja MBChB, MMED, PhD; Department of Psychiatry, Makerere University drnoeline{at}yahoo.com
Data Availability
The codebook analyzed during the current study is available from the corresponding author
